Compugen to Present at Jefferies 2014 Global Healthcare Conference in London
November 12 2014 - 6:01AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN) today announced that Dr. Anat
Cohen-Dayag, President and Chief Executive Officer of Compugen,
will present a corporate overview and update at the Jefferies 2014
Global Healthcare Conference in London, UK.
The Compugen presentation is scheduled to start at 10:40 a.m.
GMT on Thursday, November 20, 2014. The presentation will be
available online on the Investors page of the Company’s
website. An archive of the event will also be available for a
period of 90 days after the presentation.
About Compugen
Compugen is a leading drug discovery company focused on
therapeutic proteins and monoclonal antibodies to address important
unmet needs in the fields of oncology and immunology. The
Company utilizes a broad and continuously growing integrated
infrastructure of proprietary scientific understandings and
predictive platforms, algorithms, machine learning systems and
other computational biology capabilities for the in
silico (by computer) prediction and selection of product
candidates, which are then advanced in its Pipeline Program. The
Company's business model includes collaborations covering the
further development and commercialization of product candidates at
various stages from its Pipeline Program and various forms of
research and discovery agreements, in both cases providing Compugen
with potential milestone payments and royalties on product sales or
other forms of revenue sharing. Compugen’s wholly-owned U.S.
subsidiary located in South San Francisco is developing monoclonal
antibody therapeutic candidates against its drug targets. For
additional information, please visit Compugen's corporate website
at www.cgen.com.
Compugen Ltd.Tsipi Haitovsky, +972-52-598-9892Global Media
Liaisontsipih@cgen.com
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024